ICRA has upgraded GSP Crop Science Limited's long-term credit rating to 'A+' (Stable) from 'A' (Stable) for ₹516.16 crore in debt.
The upgrade acknowledges an improvement in the company's operating performance during FY2025 and the first nine months of FY2026, along with a stronger financial profile that emerged after its recent Initial Public Offering (IPO).
An 'A+' rating indicates stronger creditworthiness and lower risk for lenders. This typically means GSP Crop Science could secure better borrowing terms, such as lower interest rates, and gain easier access to capital for future needs. The rating also signals enhanced financial stability to investors.
The company, a significant player in India's agrochemical market, has focused on financial improvement. After its IPO in March 2026, GSP Crop Science used funds to reduce debt. Earlier positive ratings in 2025 from India Ratings and ICRA also noted its debt reduction, better profitability, and stronger finances. The company has also worked on backward integration to boost its manufacturing capabilities.
ICRA may review the rating if circumstances change. The agrochemical sector itself faces risks, including weather patterns and changing regulations. GSP Crop Science's business remains intensive in its use of working capital, with substantial levels of receivables and inventory often observed.
In comparison, other Indian agrochemical companies like Saraswati Agro Chemicals India Pvt Ltd and Crop Chemicals India Ltd. hold ratings around 'CRISIL BBB+/Stable' and 'CRISIL BBB/Stable' respectively. Industry leaders, such as Bayer CropScience Ltd., have much higher ratings like 'CRISIL AAA/Stable'.
ICRA will monitor the rating over the next year. Investors will likely watch GSP Crop Science's debt levels and how it manages its working capital. Continued strong operating performance and sustained profitability will be key for the company.
